Sarcoma & GIST
News
Ridaforolimus Fails to Sway FDA Panel in Sarcoma Bid
News
FDA Panel Backs Pazopanib for Sarcoma
News
FDA Panel to Assess Ridaforolimus, Pazopanib for Sarcoma
News
Primary GIST Carries Poorer Prognosis When Outside GI Tract
Major Finding: The 10% of patients whose primaries were outside the gastrointestinal tract had a 28% increased risk of death after adjustment for...
News
Neoadjuvant Therapy Improves Survival of Large Sarcomas in Extremities
Major Finding: Among patients with soft-tissue sarcomas of the extremities measuring longer than 5 cm, 3-year overall survival was 63% for those...